| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
SUSAR's in the EEA | |
| |
March 14, 2008 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, Online
Apr 15 2008
Join us online for a 90 minute webinar to learn more about SUSAR Reporting for Interventional Clinical Trials in the EEA. WEBINAR HIGHLIGHTSIn this webinar we will look at the following documents:·Directive 2001/20/EC (alias Clinical Trials Directive and Good Clinical Practice Directive) ·Volume 10: Notice to Applicants. Special emphasis will be given in the areas of responsibilities of the sponsor, adverse event concept, reporting rules to EudraVigilance and prerequisites for reporting to EudraVigilance.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
THOMAS STEINBACH, MD, PhD, FFPM (Dis) Qualified Person for Pharmacovigilance, SeniorDirector GSSELWyeth Europa Ltd., UK.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16993&eventType=Webinar
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|